Retatrutide is a GGG tri-agonist that targets GLP-1 and GIP receptors while uniquely activating the glucagon receptor. This additional receptor interaction boosts glucagon production, promoting the breakdown of stored fats and glycogen, which increases basal metabolism and supports more consistent fat loss. By acting on GLP-1 and GIP receptors, Retatrutide also delays gastric emptying and enhances appetite control, providing a multifaceted approach to obesity research that sets it apart from traditional GLP-1 agonists. While its potential benefits are promising, further research is required to fully understand its therapeutic applications.
Retatrutide – 10mg
$150.00
(AEEA)-y-Glu-C20 diacid
ACCeS-NH2
Sequence: YA1QGTFTSDYSIL2LDKK4AQA1AFIEYLLEGGPSSGAPPPS3
Molecular Formula: C223H343F 3N46070
Molecular Weight: 4845.44 g/mol
PubChem SID: 474492335
CAS Number: 2381089-83-2
Synonyms: LY-3437943, NOP2Y096GV
Description
Reviews (0)
Shipping & Delivery
MAECENAS IACULIS
Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.
ADIPISCING CONVALLIS BULUM
- Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
- Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
- Diam parturient dictumst parturient scelerisque nibh lectus.
Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisque vestibulum amet elit ut volutpat.
Reviews
There are no reviews yet.